A Phase III, observer-blind, randomized, active controlled study
Latest Information Update: 01 Oct 2018
Price :
$35 *
At a glance
- Drugs Meningococcal vaccine group A conjugate (Primary)
- Indications Meningococcal group A infections; Meningococcal infections
- Focus Adverse reactions
- Sponsors PATH
- 14 Mar 2012 Status changed from active, no longer recruiting to completed as reported by Pan-African Clinical Trials Registry.
- 17 Sep 2011 New trial record